157 related articles for article (PubMed ID: 2558001)
1. [Calcium channel as molecular target of drug action].
Taglialatela M; Annunziato L; Marino A
Clin Ter; 1989 Dec; 131(5):299-305. PubMed ID: 2558001
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological aspects of calcium channel blockers: therapeutic implications].
Mill JG; Vassallo DV; Vasquez EC
Arq Bras Cardiol; 1987 Apr; 48(4):255-65. PubMed ID: 3328598
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of calcium antagonists.
Millar JA; Bramley PM
Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):205-11. PubMed ID: 6379348
[No Abstract] [Full Text] [Related]
4. [Pharmacological properties and use of calcium channel blockers].
Kostowski W; Obersztyn M
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1701-5. PubMed ID: 6395120
[No Abstract] [Full Text] [Related]
5. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological introduction to the clinical use of calcium antagonists].
Ferrari R; Boraso A; De Giuli F; Cargnoni A; Pasini E; Condorelli E; Boffa GM; Visioli O
G Ital Cardiol; 1988 Nov; 18(11):956-69. PubMed ID: 2854799
[No Abstract] [Full Text] [Related]
7. [Pharmacology of calcium antagonists].
Klaus W
Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816
[TBL] [Abstract][Full Text] [Related]
8. [Cav channels and Ca2+ antagonists: recent advances in molecular characteristics and pharmacology].
Endoh M
Clin Calcium; 2006 Jan; 16(1):12-8. PubMed ID: 16397345
[TBL] [Abstract][Full Text] [Related]
9. [Calcium antagonists--their clinical use].
Draganov V
Vutr Boles; 1985; 24(2):29-36. PubMed ID: 3898584
[No Abstract] [Full Text] [Related]
10. Calcium-entry blockers: a review of their basic and clinical pharmacology and therapeutic applications.
Schneck DW
Ration Drug Ther; 1985 May; 19(5):1-6. PubMed ID: 3903863
[No Abstract] [Full Text] [Related]
11. [Criteria of the clinical application of Ca++ antagonists].
Kishida H; Saito H; Hayakawa H
Nihon Rinsho; 1982; 40(11):2477-83. PubMed ID: 6218317
[No Abstract] [Full Text] [Related]
12. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
13. Calcium-antagonist drugs.
Abernethy DR; Schwartz JB
N Engl J Med; 1999 Nov; 341(19):1447-57. PubMed ID: 10547409
[No Abstract] [Full Text] [Related]
14. [Calcium antagonists].
Bracchetti D; Fulvi M
Medicina (Firenze); 1988; 8(4):379-98. PubMed ID: 3072459
[No Abstract] [Full Text] [Related]
15. [Tissue selectivity of calcium channel blockers].
Godfraind T
C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358
[TBL] [Abstract][Full Text] [Related]
16. Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium.
Cain BS; Meldrum DR; Cleveland JC; Meng X; Banerjee A; Harken AH
J Mol Cell Cardiol; 1999 Dec; 31(12):2191-7. PubMed ID: 10640446
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists].
Adachi-Akahane S
Clin Calcium; 2005 Oct; 15(10):1589-97. PubMed ID: 16199903
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
Apostolakos MJ; Varon ME
New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
[TBL] [Abstract][Full Text] [Related]
19. Some similarities and differences between verapamil and the dihydropyridines.
Antonios TF; MacGregor GA
J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094
[TBL] [Abstract][Full Text] [Related]
20. [Calcium antagonists in cardiology].
Tullio D; Valerio A; D'Agostino F
Clin Ter; 1983 Jan; 104(1):27-51. PubMed ID: 6337771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
